This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wenting, G. J. Articles by Schalekamp, M. A. Search for Related Content PubMed PubMed Citation Articles by Wenting, G. J. Articles by Schalekamp, M. A. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB FUROSEMIDE PHENYLEPHRINE PRAZOSIN HYDROCHLORIDE Medline Plus Health Information High Blood Pressure

Hypertension, Vol 6, 100-109, Copyright © 1984 by American Heart Association

ARTICLES

5-HT, alpha-adrenoceptors, and blood pressure. Effects of ketanserin in essential hypertension and autonomic insufficiency

GJ Wenting, AJ Woittiez, AJ Man in't Veld and MA Schalekamp

The serotonin (5-hydroxytryptamine, 5-HT) antagonist, ketanserin, has a high affinity for 5-HT2-receptors but it also binds to alpha 1- adrenoceptors. The compound (10 mg i.v.) lowered mean arterial pressure by 22% +/- 2% (mean +/- SEM, p less than 0.001) in 30 patients with essential hypertension. Measurements of heart rate, cardiac output, cardiac filling pressures, forearm blood flow, renal blood flow, and glomerular filtration rate revealed a hemodynamic pattern compatible with vasodilation of both resistance and capacitance vessels. This was accompanied by moderate reflex cardiostimulation. Ketanserin did not alter the pressor effect of bolus injections of (-)-phenylephrine hydrochloride (25, 50, 100, and 200 micrograms i.v.). Ketanserin also had a distinct hypotensive effect in four normotensive patients with autonomic insufficiency due to an efferent sympathetic lesion, who were unresponsive to phentolamine (20 mg i.v.). Thus, ketanserin in the dose we have used appears to lower blood pressure independently of alpha 1- adrenoceptor blockade. On the other hand, in patients with essential hypertension the antihypertensive effect of ketanserin was blunted by pretreatment with prazosin (12 mg/day). Therefore, a certain degree of alpha 1-adrenergic tone seems to be required for the compound to exert its full antihypertensive action. The findings are indirect evidence for a role of 5-HT in the maintenance of increased vascular resistance in essential hypertension. This may be related, at least in part, to the alleged amplifying effect of 5-HT on alpha 1-adrenoceptor-mediated vasoconstriction.

This article has been cited by other articles:

				P. J. A. van der Starre, R. S. Reneman, and H. W. Scheijgrond Ketanserin in the Treatment of Systemic Hypertension During and Following Coronary Artery Bypass Surgery Angiology, November 1, 1989; 40(11): 1001 - 1010. [Abstract] [PDF]

				S. G. Sheps, A. Schirger, P. K. Zachariah, L. D. Fisher, R. E. Spiekerman, F. J. Araas, J. B. Collins, and D. C. Agerter Comparison of Ketanserin and Metoprolol in the Treatment of Essential Hypertension Arch Intern Med, February 1, 1987; 147(2): 291 - 296. [Abstract] [PDF]

				R.A. Boas Intra Arterial Ketanserin in Peripheral Vascular Disease Angiology, April 1, 1986; 37(4): 267 - 271. [Abstract] [PDF]